Next Article in Journal
Expression Profiles of Circulating MicroRNAs in XELOX-Chemotherapy-Induced Peripheral Neuropathy in Patients with Advanced Gastric Cancer
Previous Article in Journal
Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer—Systematic Review
Previous Article in Special Issue
Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro
 
 
Review

Lignans as Pharmacological Agents in Disorders Related to Oxidative Stress and Inflammation: Chemical Synthesis Approaches and Biological Activities

1
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia
2
Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia
*
Author to whom correspondence should be addressed.
Academic Editors: Natália Cruz-Martins and Roberta Fusco
Int. J. Mol. Sci. 2022, 23(11), 6031; https://doi.org/10.3390/ijms23116031
Received: 29 April 2022 / Revised: 17 May 2022 / Accepted: 24 May 2022 / Published: 27 May 2022
Plant lignans exhibit a wide range of biological activities, which makes them the research objects of potential use as therapeutic agents. They provide diverse naturally-occurring pharmacophores and are available for production by chemical synthesis. A large amount of accumulated data indicates that lignans of different structural groups are apt to demonstrate both anti-inflammatory and antioxidant effects, in many cases, simultaneously. In this review, we summarize the comprehensive knowledge about lignan use as a bioactive agent in disorders associated with oxidative stress and inflammation, pharmacological effects in vitro and in vivo, molecular mechanisms underlying these effects, and chemical synthesis approaches. This article provides an up-to-date overview of the current data in this area, available in PubMed, Scopus, and Web of Science databases, screened from 2000 to 2022. View Full-Text
Keywords: lignan; antioxidant; oxidative stress; anti-inflammatory; inflammation; chemical synthesis lignan; antioxidant; oxidative stress; anti-inflammatory; inflammation; chemical synthesis
Show Figures

Figure 1

MDPI and ACS Style

Osmakov, D.I.; Kalinovskii, A.P.; Belozerova, O.A.; Andreev, Y.A.; Kozlov, S.A. Lignans as Pharmacological Agents in Disorders Related to Oxidative Stress and Inflammation: Chemical Synthesis Approaches and Biological Activities. Int. J. Mol. Sci. 2022, 23, 6031. https://doi.org/10.3390/ijms23116031

AMA Style

Osmakov DI, Kalinovskii AP, Belozerova OA, Andreev YA, Kozlov SA. Lignans as Pharmacological Agents in Disorders Related to Oxidative Stress and Inflammation: Chemical Synthesis Approaches and Biological Activities. International Journal of Molecular Sciences. 2022; 23(11):6031. https://doi.org/10.3390/ijms23116031

Chicago/Turabian Style

Osmakov, Dmitry I., Aleksandr P. Kalinovskii, Olga A. Belozerova, Yaroslav A. Andreev, and Sergey A. Kozlov. 2022. "Lignans as Pharmacological Agents in Disorders Related to Oxidative Stress and Inflammation: Chemical Synthesis Approaches and Biological Activities" International Journal of Molecular Sciences 23, no. 11: 6031. https://doi.org/10.3390/ijms23116031

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop